You are currently viewing a new version of our website. To view the old version click .

Viruses, Volume 2, Issue 8

August 2010 - 20 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (20)

  • Review
  • Open Access
5 Citations
12,916 Views
22 Pages

Last Stop Before Exit – Hepatitis C Assembly and Release as Antiviral Drug Targets

  • Birke Andrea Tews,
  • Costin-Ioan Popescu and
  • Jean Dubuisson

24 August 2010

Chronic Hepatitis C infection is a global health problem. While primary infection is often inapparent, it becomes chronic in most cases. Chronic infection with Hepatitis C virus (HCV) frequently leads to liver cirrhosis or liver cancer. Consequently,...

  • Review
  • Open Access
644 Citations
34,187 Views
17 Pages

Coronavirus Genomics and Bioinformatics Analysis

  • Patrick C. Y. Woo,
  • Yi Huang,
  • Susanna K. P. Lau and
  • Kwok-Yung Yuen

24 August 2010

The drastic increase in the number of coronaviruses discovered and coronavirus genomes being sequenced have given us an unprecedented opportunity to perform genomics and bioinformatics analysis on this family of viruses. Coronaviruses possess the lar...

  • Review
  • Open Access
33 Citations
14,076 Views
18 Pages

Core as a Novel Viral Target for Hepatitis C Drugs

  • Arthur Donny Strosberg,
  • Smitha Kota,
  • Virginia Takahashi,
  • John K. Snyder and
  • Guillaume Mousseau

20 August 2010

Hepatitis C virus (HCV) infects over 130 million people worldwide and is a major cause of liver disease. No vaccine is available. Novel specific drugs for HCV are urgently required, since the standard-of-care treatment of pegylated interferon combine...

  • Review
  • Open Access
57 Citations
16,671 Views
14 Pages

Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel

  • Laurent Chatel-Chaix,
  • Martin Baril and
  • Daniel Lamarre

20 August 2010

Hepatitis C virus (HCV) infection is a serious and growing threat to human health. The current treatment provides limited efficacy and is poorly tolerated, highlighting the urgent medical need for novel therapeutics. The membrane-targeted NS3 protein...

  • Review
  • Open Access
12 Citations
8,216 Views
16 Pages

Antiviral Strategies for Pandemic and Seasonal Influenza

  • Maria Hedlund,
  • Jeffrey L. Larson and
  • Fang Fang

20 August 2010

While vaccines are the primary public health response to seasonal and pandemic flu, short of a universal vaccine there are inherent limitations to this approach. Antiviral drugs provide valuable alternative options for treatment and prophylaxis of in...

  • Review
  • Open Access
25 Citations
13,486 Views
16 Pages

Targeting HCV Entry For Development of Therapeutics

  • Flossie Wong-Staal,
  • Andrew J. Syder and
  • Jeffrey F. McKelvy

18 August 2010

Recent progress in defining the molecular mechanisms of Hepatitis C Virus (HCV) entry affords the opportunity to exploit new viral and host targets for therapeutic intervention. Entry inhibitors would limit the expansion of the infected cell reservoi...

  • Review
  • Open Access
83 Citations
21,029 Views
23 Pages

Adenoviral Producer Cells

  • Imre Kovesdi and
  • Susan J. Hedley

16 August 2010

Adenovirus (Ad) vectors, in particular those of the serotype 5, are highly attractive for a wide range of gene therapy, vaccine and virotherapy applications (as discussed in further detail in this issue). Wild type Ad5 virus can replicate in numerous...

  • Review
  • Open Access
36 Citations
8,014 Views
15 Pages

12 August 2010

A relatively new aspect of HIV-1 biology is the ability of the virus to infect cells by direct cellular contacts across a specialized structure, the virological synapse. This process was recently described through live cell imaging. Together with the...

  • Review
  • Open Access
19 Citations
11,134 Views
12 Pages

6 August 2010

Infection with Hepatitis C Virus (HCV) continues to be a major global health problem. To overcome the limitations of current therapies using interferon-a in combination with ribavirin, there is a need to develop drugs that specifically block viral pr...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Viruses - ISSN 1999-4915